Bioenergetics failure in neurodegenerative diseases: back to the future

Expert Opinion on Therapeutic Targets
Uday Saxena

Abstract

Neurodegenerative disease such as Alzheimer's, Parkinson and Huntington's are all characterized by dysfunctional neurons and loss of cognitive/motor functions. Interestingly these three diseases involve overproduction, aggregation or abnormal degradation of a specific aberrant protein, which participates in disease pathogenesis. The aggregated proteins may induce disease causing pathways such as high oxidative stress and reduced neuronal metabolism. Several mechanisms are being considered as disease-causing and there is established and growing evidence that a breakdown in neuronal energy production may be an underlying cause in these diseases. The specific risk factors and molecular drivers for each disease vary, yet there are common defective bioenergetics pathways, which may drive neuronal dysfunction. While it has been appreciated that energy deficits can drive neuronal dysfunction and disease, it has for the most part been overlooked as a target pathway for designing novel disease modifying therapeutics. This editorial reviews selected evidence supporting energy deficits as disease-causing and proposes targets for design of new therapeutics.

References

Nov 1, 1993·Journal of Neurology·T KuwertL E Feinendegen
Mar 5, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Lisa Mosconi
Dec 17, 2008·Annals of the New York Academy of Sciences·Lisa MosconiMony J De Leon
Jan 15, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Lisa MosconiMony J de Leon
Aug 18, 2009·Biochimica Et Biophysica Acta·Maria DamianoEmmanuel Brouillet
Apr 28, 2010·Human Molecular Genetics·Mark R Cookson, Oliver Bandmann
Jul 29, 2010·Physiological Reviews·Chiara ZuccatoElena Cattaneo
Oct 12, 2010·Science Translational Medicine·Bin ZhengUNKNOWN Global PD Gene Expression (GPEX) Consortium
Nov 10, 2010·Expert Opinion on Therapeutic Targets·Uday Saxena
May 17, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nicolaas I BohnenDavid E Kuhl

❮ Previous
Next ❯

Citations

Jan 7, 2015·Neurochemical Research·Pamela Maher, George J Kontoghiorghes
Sep 17, 2019·The Journal of Clinical Investigation·Rong CaiLei Liu
Jul 28, 2020·Biomolecules·Joséphine ZangariJean-Claude Martinou
Jan 10, 2021·Journal of Molecular Neuroscience : MN·Olayemi Joseph OlajidePhilip Adeyemi Adeniyi
Feb 2, 2021·JAMA Neurology·Jacob E SimmeringAnton Pottegård
Mar 6, 2021·Neurotoxicity Research·Flávia Malvestio SistiAntonio Cardozo Dos Santos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.